Pharmaceutical industry sponsored medical education;Pharmasponsoring in der ärztlichen fort- und weiterbildung

Zeitschrift fur Allgemeinmedizin

Volumn 84, Issue 12, 2008, Pages 516-524

  Schneider, N ^a   Lückmann, Sara Lena ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Conflict of interest; Drug industry; Medical education

Indexed keywords

EID: 58149510644     PISSN: 09376801     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1100421     Document Type: Article

References (27)

1. Moynihan R. Doctors' education. The invisible influence. BMJ 2008; 336: 416-417
2. MEZIS. Initiative unbestechlicher Ärztinnen und Ärzte. http://www.mezis.de (letzter Zugriff vom 13.8.2008)
3. Wazana A. Physicians and the pharmaceutical industry. JAMA 2000; 283 (3): 373-380
4. Segovis CM, Mueller PS, Rethlefsen ML, et al. If you feed them, they will come: A prospective study of the effects of complimentary food on attendance and physician attitudes at medical grand rounds at an academic medical center. BMC Medical Education 2007; 12 (7): 22
5. Eckardt VF. Complimentary journeys to the world congress of gastroenterology - an inquiry of potential sponsors and beneficiaries. Z Gastroenterol 2000; 38 (1): 7-11
6. Keim SM, Mays MZ, Grant D. Interactions between emergency medicine programs and the pharmaceutical industry. Acad Emerg Med 2004; 11 (1): 19-26
7. Carney SL, Nair KR, Sales MA, et al. Pharmaceutical industry-sponsored meetings: Good value or just a free meal? Intern Med J 2001; 31 (8): 488-491
8. Brett AS, Burr W, Moloo J. Are gifts from pharmaceutical companies ethically problematic? A survey of physicians. Arch Intern Med 2003; 163 (18): 2213-2218
9. Rutledge P, Crookes D, MacKinstry B, et al. Do doctors rely on pharmaceutical industry funding to attend conferences and do they perceive that this creates a bias in their drug selection? Results from a questionnaire survey. Pharmacoepidemiol Drug Saf 2003; 12 (8): 663-667
10. Steinman MA, Shlipak MG, MacPhee SJ. Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions. Am J Med 2001; 110 (7): 551-557
11. Randall ML, Rosenbaum JR, Rohrbaugh RM, et al. Attitudes and behaviors of psychiatry residents toward pharmaceutical representatives before and after an educational intervention. Acad Psychiatry 2005; 29 (1): 33-39
12. Halperin E, Hutchinson P, Barrier R. A population-based study of the prevalence and influence of gifts to radiation oncologists from pharmaceutical companies and medical equipment manufacturers. Int J Radiation Oncology Biol Phys 2004; 59 (5): 1477-1483
13. Varley CK, Jibson MD, MacCarthy M, et al. A survey of the interactions between psychiatry residency programs and the pharmaceutical industry. Acad Psychiatry 2005; 29 (1): 40-46
14. Loh LC, Ong HT, Quah SH. Impact of various continuing medical education activities on clinical practice - a survey of Malaysian doctors on its perceived importance. Ann Acad Med Singapore 2007; 36 (4): 281-284
15. Wofford JL, Ohl CA. Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes. BMC Medical Education 2005; 8; 5 (1): 5
16. Schneider JA, Arora V, Kasza K, et al. Residents' perceptions over time of pharmaceutical industry interactions and gifts and the effect of an educational intervention. Acad Med 2006; 81 (7): 595-602
17. Agrawal S, Saluja I, Kaczorowski J. A prospective before-and-after trial of an educational intervention about pharmaceutical marketing. Acad Med 2004; 79 (11): 1046-1050
18. Tillmanns RW, Ringwelski A, Kretschmann J, et al. The profession of medicine: a joint US-German collaborative project in medical education. Med Teach 2007; 29 (9): e269-75
19. MacCormick BB, Tomlinson G, Brill-Edwards P, et al. Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior. JAMA 2001; 286 (16): 1994-1999
20. Watkins RS, Kimberly J. What residence don't know about physician-pharmaceutical industry interactions. Acad Med 2004; 79 (5): 432-437
21. Kerridge I, Maguire J, Newby D, et al. Cooperative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organizations. Intern Med J 2005; 35: 206-210
22. Ashar BH, Miller RG, Getz KJ, et al. Prevalence and determinants of physician participation in conducting pharmaceutical-sponsored clinical trials and lectures. J Gen Intern Med 2004; 19 (11): 1140-1145
23. Panorama Nr. 686 vom 16.8.2007. Trotz Verbot - Pharmakonzerne manipulieren Ärztefortbildung http://daserste.ndr.de/panorama/archiv/2007/ erste4300.pdf (letzter Zugriff am 13.8.2008)
24. Bundesärztekammer: Dokumentation zum 110 Deutschen Ärztetag. Dtsch Ärztebl 2007; 104 (21): A1519-A1532
25. Chakrabarti A, Fleisher WP, Staley D, et al. Interactions of staff and residents with pharmaceutical industry: A survey of psychiatric training program policies. Ann R Coll Physicians Surg Can 2002; 35 (8): 541-546
26. Watson PY, Khandelwal AK, Musial JL, et al. Resident and faculty perceptions of conflict of interest in medical education. J Gen Intern Med 2005; 20 (4): 357-359
27. Katz HP, Goldfinger SE, Fletcher SW. Academia-industry collaboration in continuing medical education: description of two approaches. J Contin Educ Health Prof 2002; 22 (1): 43-54